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INTRODUCTION
Parkinson's disease (PD) is the second most common neurodegenerative disease with a worldwide prevalence greater than 1% in adults over 70 [1] . Early motor symptoms include rigidity, bradykinesia, tremor and gait impairment with postural instability emerging as the disease progresses [2] . Postural instability is a known predictor of falls with consequential impact on wellbeing [3] . Over 20% of people with PD have also been reported to have mild cognitive impairment (MCI) at initial diagnosis [4] . Changes in cognitive function are associated with postural instability [5, 6] and with an increased risk of falls [7, 8] . A neuroimaging study supports the link between cognitive function and falling in PD with reduced grey matter reported in the posterior caudate (associated with cognitive function) in fallers compared to fallers [8] . Management of postural instability is challenging as it is often resistant to dopaminergic therapy [9] . Nonpharmaceutical interventions include different treadmill training protocols which show limited improvements in gait and balance [10, 11] .
Clinically, assessment of postural instability is the Pull test, included in the Unified
Parkinson's Disease Rating Scale (UPDRS III), which is insensitive to small changes in postural stability [12] . Objectively, postural stability has been assessed through centre of pressure (COP) parameters recorded from a force platform [13] and more recently, from body-worn monitors such as accelerometers [14] [15] [16] . The derived postural parameters are generally linear, providing information about signal characteristics averaged across time.
However, as postural stability is a function of postural control, parameters that reflect underlying neural control mechanisms may yield additional information. For example, people with PD have reduced automatic control and greater conscious control of posture [17, 18] .
This altered regulatory mechanism may present as a change in regularity or predictability of postural parameters. 6 The purpose of this study was to investigate predictability of postural trunk dynamics through nonlinear analysis of tri-axial accelerometer signals. We included vertical accelerometry data as postural control operates in three dimensions and changes in perception of the postural vertical in older adults have been postulated [19] . We compared postural trunk predictability in people with recently diagnosed PD to postural trunk predictability in healthy older adults (HOA). Additionally, we investigated changes in this parameter over a 36 month period and its relationship to cognitive dysfunction. We hypothesised that (1) Postural trunk predictability is different in people with PD due to the loss of automatic control; (2) Postural trunk predictability changes over time in people with PD, as a result of increasing loss of automatic motor behaviour; (3) Postural trunk predictability is correlated with clinical measures of cognitive dysfunction, reflecting common dysfunctional neural pathways. This analysis may offer information about the underlying postural control mechanisms, its application as an early biomarker and as an indicator of disease progression. assessments were undertaken at approximately 18 months, 36 months and 54 months after the baseline assessment. All participants were monitored for at least two of the three sessions and all had an assessment at 54 months to eliminate bias that may arise from the more severely impaired participants leaving the study early (Table 1) .
METHODS
Study design
Participants
Participants were excluded if they had any neurological (other than PD), orthopaedic or cardiothoracic conditions that may have markedly affected their walking or safety during the testing sessions. Diagnosis of idiopathic PD was made according to the UK Parkinson's Disease Brain Bank criteria. Exclusion criteria included significant memory impairment (Mini Mental State Exam (MMSE) < 24 [6] ), dementia with Lewy bodies or poor command of English. This study was conducted according to the declaration of Helsinki and all participants signed an informed consent form prior to testing.
Demographic and clinical measures
Age, sex and body mass index (BMI) were recorded for each participant. Cognitive tests included the MMSE [20] and also the Montreal Cognitive Assessment (MoCA), which discriminates more effectively MCI and dementia in PD [21] . The UPDRS III was used to assess the level of motor dysfunction with values raging from 0 (no motor symptoms) to 132 (severe motor symptoms) [22] .
Standing balance test
Participants were instructed to stand still, with shoes on, hands by their sides, within a rectangular area (400 mm wide × 600 mm long), while looking straight ahead for 2 minutes.
Stance width was not controlled for. The PD participants were tested approximately 1 hour after medication intake.
Equipment
A single tri-axial accelerometer (Axivity AX3, York, UK) on the lower back recorded acceleration at a sampling rate of 100 Hz [14] .
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Data processing
The tri-axial accelerometry data were exported to the MATLAB ® (R2015a, Mathworks, Natick, MA) environment, downsampled to 10 Hz and rotated using the Moe-Nilssen transformation into anteroposterior, mediolateral and vertical accelerations [14, 23] . No filtering was applied. A nonlinear method that quantifies predictability is sample entropy (SampEn), defined as the logarithmic probability that two sequences, similar for m points extracted from a time-series, will remain similar at a sequence length of m + 1 [24] . Higher values of SampEn indicate low predictability whereas lower values indicate high predictability. SampEn was calculated for accelerations along the three axes, using the method described by Richman and Moorman (2000) [24] . Signal nonlinearity was assessed by applying the rank sum test to SampEn values for nineteen surrogate signals generated using the Iterated Amplitude Adjusted Fourier Transform (IAAFT) which preserves the power spectrum and linear correlations [27] .
Data analysis
Only nonlinear signals, those with SampEn less than the surrogate signals' SampEn, were included in the analysis as application of nonlinear methods requires the timeseries to contain nonlinear structures. All statistical analyses were performed in SPSS (v21, IBM, Chicago, Il., USA), p < 0.05. Differences in SampEn between groups (i.e., people with PD vs HOA ) and time-point (i.e., 18 months, 36 months and 54 months) were analysed using linear mixed models, which models missing data, and regression analysis. Sidak corrections for multiple comparisons were applied to the post hoc analyses. Pearson's and Spearman's correlation were used to explore associations between SampEn and MoCA, MMSE and UPDRS III.
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RESULTS
Demographic and cognitive data
The age range of participants across the three time-periods was 44.9-92.0 years for the PD group and 53.7-90.8 years for the HOA. The PD group were significantly younger (F1, 280=10.3, p=0.001). There was a smaller proportion of females in the PD group compared to the HOA group (34% versus 44%), and they had a lower MoCA score (F1, 280=7.3, p=0.007) ( Table 1) . MoCA, MMSE and UPDRS III are semi-quantitative in nature [28] and have a ceiling effect which may account for the weak correlations in addition to the heterogenous nature of the PD group. We therefore report on weak correlations, r>0.2.
Sample entropy a) Signal nonlinear characterization
i) Cognitive clinical scores
There was a weak negative correlation between SampEn and both MoCA and MMSE scores along the anteroposterior and vertical axes at 54 months (Table 2, Figure 3) , with better cognitive function associated with lower SampEn. Additionally, SampEn in the vertical direction was negatively correlated at 36 months with cognitive scores (Table 2, Figure 3 ).
There was no correlation greater than 0.2 between SampEn in the mediolateral direction and cognitive measures for any time-point (Table 2) .
ii) Motor Clinical Score (UPDRS III)
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SampEn along all 3 axes showed positive correlations with UPDRS III, although at differing time-points ( was higher for older adult ice-skaters than non-skating older adults and similar to young adults [31] . They concluded that the greater postural unpredictability in older adult skaters represents greater signal complexity and improved ability to respond to perturbations. In our study, we have observed that SampEn is greater in people with PD indicating less predictability. However, SampEn does not provide a measure of complexity as random signals have higher SampEn [32] .
The increased SampEn in the people with PD indicates altered postural motor control which may be explained by impairment of neural pathways associated with sensorimotor integration and cortical regions involved with habitual control of movement [33] . This neural dysfunction will impact the closed-loop system of postural motor control with diminished fine adjustments in response to internal and external sensory changes resulting in greater irregularity in postural movements. This explanation is supported by a study investigating finger pressures in people with PD when compressing a spring. Nonlinear attractor reconstruction was applied to the pressures and weaker attractors and more chaotic phase portraits were found in people with PD compared to older adults suggesting impairment of closed-loop motor control [34] .
Temporal changes in sample entropy. The time-period was significant only for SampEn in the anteroposterior direction across both groups, with a decrease tending to significance between 18 months and 54 months. These findings are similar to a study investigating accelerometry linear metrics over a 12 month period in HOA and people with PD [15] . This Lower postural predictability is associated with greater movement impairment. SampEn correlated positively although weakly, with the UPDRS III, indicating lower postural predictability is associated with greater movement impairment. This finding is surprising as the UPDRS III contains only one test, the Pull test, that relates directly to postural instability [12] . The positive association suggests that temporal structure of postural movement is an indicator of more general motor control function. A previous study reported no correlation between linear acceleration parameters (e.g. jerk) and UPDRS III [16] . However, none of the patients in Mancini et al.'s study were on dopaminergic or other antiparkinsonian treatment, whereas in our study all patients were on medication. Levodopa has been reported to increase postural sway [36] . Correlation analysis between levodopa equivalent dose (LEDD) and another study which reported that mediolateral sway measures are more sensitive at detecting differences in sway than anteroposterior measures [15] . Sensorimotor integration is differentially affected leading to diverse ankle and hip/trunk strategies with hip/trunk strategy more associated with lateral sway [37] . An additional explanation is that people with PD have a smaller stance width which is likely to result in greater ML movement [38, 39] . A negative weak correlation was found between SampEn in the anteroposterior direction and cognitive function. Riley et al. reported a similar link between postural nonlinear measures in the anteroposterior direction and cognitive tasks but not the mediolateral direction [40] .
Limitations.
15
This study has several limitations. We investigated a small number of people with PD presenting with diverse phenotypes who received different types and dosages of medication.
They also varied in extent of postural impairment and level of cognitive function. Many of the older and PD participants had additional co-morbidities, such as low back pain or lower limb joint degeneration that may account for some of the differences in trunk acceleration.
Stance width was not controlled for, which might have affected acceleration. Another limitation is that not all participants were present for all three sessions. However, we applied the linear mixed model which models the missing data. A further limitation is that several signals we included as deterministic, may have been identified as nondeterministic if we had increased the number of surrogates. The MoCA, MMSE and UPDRS III scores are semiquantitative and have a ceiling effect which may account for the weak correlations we found. Examination, UPDRS -Unified Parkinson's Disease Rating Scale, n/a -not applicable.
CONCLUSION
* represents significant differences between PD and HOA (p < 0.05).
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